Thank you for posting this link. It is interesting to note that as per the abstract, it mentioned that "As of Aug 2023, we report early results from seven patients with GI malignancies who received CF33-hNIS alone".
We were first notified for this result on 6 November 2023 from the ASX annoucement "Phase 1 CF33-hNIS (VAXINIA) Study Update - Positive Early Signals" and another study update on 17 January 2024.
There is timing gap of 2 months or more between the results being reported and the results being annouced. Hope the coming 2024 AACR will release more data or results for the period from January 2024 to March 2024 (maybe or maybe not?)
Thank you for posting this link. It is interesting to note that...
-
- There are more pages in this discussion • 5,259 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
0.002(4.65%) |
Mkt cap ! $334.7M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.5¢ | 4.3¢ | $732.0K | 16.76M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1799587 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 1003772 | 13 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |